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to a family of LAT RNAs, including the very stable 2-kb LAT
(15, 18, 19), which appears to be an intron produced by splicing
(4).
HSV-1 LAT null mutants that are unable to transcribe any
of the LAT gene have reduced reactivation phenotypes. Thus,
LAT transcription-negative mutants reactivate poorly by induced reactivation in the mouse (7, 8, 16), by induced reactivation in the rabbit (2, 17), and by spontaneous reactivation in
the rabbit (11, 12). Thus, a high reactivation phenotype requires LAT. The term reactivation phenotype is used here
because these experiments use reactivation as a phenotype
without regard to whether LAT enhances this phenotype directly (i.e., affects the reactivation process), indirectly (i.e.,
affects establishment or maintenance of latency, thereby increasing the pool of latently infected neurons), or both.
LAT3.3A, an HSV-1 strain McKrae mutant expressing just
the first 1.5 kb of the primary 8.3-kb LAT has a high, McKraelike spontaneous reactivation phenotype in rabbits (3, 12).
Thus, the first 1.5 kb of LAT alone is sufficient for high levels
of spontaneous reactivation in the rabbit (12). Comparative
sequence analysis of this region suggests that there is no well-

Following ocular herpes simplex virus type 1 (HSV-1) infection, the virus travels up nerves to the trigeminal ganglia (TG),
where it establishes a latent infection lasting for life. A hallmark of HSV-1 latency is sporadic reactivation and the return
of the virus to the original peripheral site of infection, where
recurrent disease may result. When HSV-1 is latent in the TG,
the recurrent disease following reactivation can lead to scarring of the cornea and loss of sight. In developed nations,
HSV-1 is the most common cause of corneal blindness due to
an infectious agent (9). How HSV-1 establishes, maintains, and
reactivates from latency remains to be fully elucidated.
During neuronal latency, a single HSV-1 gene is abundantly
transcribed. This gene, designated the latency-associated transcript (LAT), is located in the long repeat region of the viral
genome and is thus diploid (i.e., present in two copies per
genome). The primary LAT transcript is 8.3 kb and gives rise
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The herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) gene is essential for the high
spontaneous and induced reactivation phenotype of HSV-1 in the rabbit ocular model and for the high induced
reactivation phenotype in the mouse ocular model. Recently we showed that LAT has an antiapoptosis function,
and we hypothesized that LAT’s ability to inhibit apoptosis played an important role in LAT’s ability to
enhance the reactivation phenotype. Expression of just the first 1.5 kb of the 8.3-kb LAT gene is sufficient for
both inhibition of apoptosis in an in vitro transient-transfection assay and the high spontaneous reactivation
phenotype in vivo. Here we show the results of more complex mapping studies in which inhibition of apoptosis
and the enhanced spontaneous reactivation phenotype also appear to be linked. The HSV-1 mutant virus
dLAT371 has a high spontaneous reactivation phenotype in rabbits, suggesting that the LAT region deleted in
this mutant (LAT nucleotides 76 to 447) is not required for this phenotype. The LAT3.3A viral mutant (which
expresses LAT nucleotides 1 to 1499) also has a high spontaneous reactivation phenotype, suggesting that the
region of LAT not expressed by this mutant (LAT nucleotide 1500 to the end of LAT) is also not required for
this phenotype. Surprisingly, LAT2.9A, which is a combination of dLAT371 and LAT3.3A (i.e., it expresses LAT
nucleotides 1 to 76 and 447 to 1499), has a low spontaneous reactivation phenotype indistinguishable from that
of LAT null mutants. We report here that consistent with the low spontaneous reactivation phenotype of
LAT2.9A, a plasmid expressing the identical LAT RNA did not inhibit caspase 9-induced apoptosis. In contrast, plasmids containing the same deletion but able to transcribe up to or past LAT nucleotide 2850 (rather
than just up to LAT nucleotide 1499) inhibited caspase 9-induced apoptosis, consistent with the high spontaneous reactivation phenotype of dLAT371. Thus, LAT2.9A may have a low spontaneous reactivation phenotype because the LAT RNA that is made cannot block apoptosis, and dLAT371 apparently has a high spontaneous reactivation phenotype because the LAT RNA made has significant antiapoptosis activity. Furthermore,
LAT appeared to have at least two regions capable of interfering with caspase 9-induced apoptosis. One region
partially overlaps LAT nucleotides 76 to 447. The second region is partially (or completely) downstream of LAT
nucleotide 1499.
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suggest that LAT2.9A has a LAT null spontaneous reactivation phenotype because the LAT RNA made cannot block
apoptosis, while dLAT371 has a wild-type spontaneous reactivation phenotype because the LAT RNA made has significant
antiapoptosis activity. These results strengthen the mapping
correlation between LAT’s antiapoptosis activity and its ability
to enhance the reactivation phenotype and therefore add additional strong support for the hypothesis that LAT’s antiapoptosis activity is functionally related to its ability to enhance the
reactivation phenotype. These results also suggest that LAT
contains at least two regions capable of inhibiting apoptosis
and that sequences between nucleotides 76 and 447 are important for the antiapoptotic activity when only the first 1,500
nucleotides are expressed.
Structures of LAT in mutant viruses referred to in this
study. The viruses referred to in this report are shown schematically in Fig. 1. McKrae is the wild-type parent for all of the
mutants. dLAT2903 is a true LAT null mutant that makes no
LAT RNA. Both copies of LAT (one in each viral long repeat)
have the core LAT promoter, a putative secondary LAT promoter just upstream of the 2-kb LAT, and the first 1,667
nucleotides of the primary LAT RNA deleted (11). This mutant has a significantly reduced spontaneous reactivation phenotype, indicating that LAT is essential for the high wild-type
spontaneous reactivation phenotype in the rabbit infection
model. dLAT371 contains a deletion in both copies of LAT
corresponding to a StyI-StyI restriction fragment from LAT
nucleotides 76 to 447. This mutant expresses normal amounts
of the remainder of LAT and has a wild-type spontaneous
reactivation phenotype (13). This suggests that LAT nucleotides 76 to 447 are not required for the high spontaneous
reactivation phenotype. LAT3.3A contains a LAT restriction
fragment inserted into the UL region of dLAT2903 between
the UL37 and UL38 genes. The LAT insert contains the entire
LAT promoter and the first 1.5 kb of the primary LAT RNA.
LAT3.3A effectively has LAT nucleotides 1500 to 8324 deleted, as it expresses just the first 1.5 kb of the primary LAT
(LAT nucleotides 1 to 1499). This region contains approximately 660 nucleotides upstream of the 2-kb LAT and the first
838 nucleotides of the 2-kb LAT. This mutant has a high
spontaneous reactivation phenotype, demonstrating that the
first 1.5 kb of LAT is sufficient to produce a wild-type spontaneous reactivation phenotype and that LAT nucleotides 1500 to
8324 are not required (12). LAT2.9A is identical to LAT3.3A
except that the LAT insert contains the same StyI-StyI deletion
(LAT nucleotides 76 to 447) as dLAT371. Since the wild-type
spontaneous reactivation phenotypes of dLAT371 and LAT3.3A
showed that LAT nucleotides 76 to 447 and 1500 to 8324 are not
required for the wild-type spontaneous reactivation phenotype, it
was expected that LAT2.9A, which contains both deletions, would
have a wild-type spontaneous reactivation phenotype. However,
unexpectedly, LAT2.9A has a reduced spontaneous reactivation
phenotype indistinguishable from that of dLAT2903 (14).
LAT-containing plasmids used in this study. The regions of
LAT expressed by the viruses and plasmids relevant to this
report are shown schematically in Fig. 2. Figure 2A shows
the full-length 8.3-kb primary LAT expressed by wild-type
McKrae. Figure 2B shows the LAT RNAs expressed by the
dLAT371 mutant and by two corresponding plasmids that have
the same StyI-StyI deletion. pLAT(1-4658)⌬Sty expresses the
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conserved LAT open reading frame (3). Thus, unless unreported splicing occurs in this region, it is unlikely that LAT’s
function is due to a LAT protein. The primary LAT completely
overlaps the important immediate-early gene ICP0 in an antisense direction (20), suggesting an antisense regulatory role for
LAT. However, the first 1.5 kb of LAT does not overlap any of
ICP0. Thus, antisense repression of ICP0 by LAT is not essential for LAT’s ability to enhance the reactivation phenotype in
the rabbit ocular model.
Recently we showed that rabbits ocularly infected with the
LAT null mutant dLAT2903 had significantly increased apoptosis in their TG compared to rabbits ocularly infected with
wild-type or marker-rescued virus (10). This difference was
observed on days 7 and 10 postinfection, at the end of the acute
infection (establishment of latency), but not on day 3 postinfection, during peak acute infection. This suggests that LAT,
the only viral gene remaining highly active following the acute
infection, was protecting against virus-induced apoptosis. No
difference was seen between LAT⫺ and LAT⫹ viruses on day
3 postinfection, because HSV-1 has several antiapoptosis
genes that are expressed at this time. We have also shown that
plasmids expressing LAT have antiapoptosis activity in vitro (6,
10). LAT’s antiapoptosis activity both in vitro and in mice has
been confirmed by others (1; S. E. Straus, personal communication).
We also showed that a plasmid expressing just the first 1.5 kb
of LAT can efficiently block apoptosis induced by a variety of
chemicals (6). This is consistent with the wild-type reactivation
phenotype of LAT3.3A, which also expresses just the first 1.5
kb of LAT, and strengthens the hypothesis that LAT’s antiapoptosis activity is functionally related to its ability to enhance
the reactivation phenotype.
In this report we try to shed some light on an unexplained
anomaly that occurred during our spontaneous reactivation
phenotype mapping in rabbits. dLAT371 expresses the entire
8.3-kb primary LAT except for a 371-nucleotide deletion from
LAT nucleotides 76 to 447. In rabbits this mutant has a wildtype spontaneous reactivation phenotype, suggesting that the
region of LAT from nucleotides 76 to 447 is not required for
this phenotype (13). LAT3.3A expresses just the first 1.5 kb of
LAT from an ectopic location in the genome of an otherwise
LAT null mutant. This mutant also has a wild-type spontaneous reactivation phenotype (12). A third mutant, LAT2.9A
(14), is identical to LAT3.3A except that LAT nucleotides 76
to 447 are deleted as in dLAT371. Since the dLAT371 data
indicated that LAT nucleotides 76 to 447 are not required and
since the LAT3.3A data suggested that LAT nucleotides downstream of nucleotide 1500 are not required, it was expected that
LAT2.9A, like LAT3.3A and dLAT371, would have a wildtype spontaneous reactivation phenotype. Instead, LAT2.9A
has a significantly reduced spontaneous reactivation phenotype, indistinguishable from that of the LAT null mutant
dLAT2903 (14).
We report here that a plasmid expressing the identical region of LAT expressed in LAT2.9A (nucleotides 1 to 76 plus
447 to 1,499) had no significant antiapoptosis activity in transient-transfection assays. In contrast, plasmids similar to the
LAT expressed by dLAT371 (containing the same deletion but
also containing at least 1.3 kb of additional LAT coding sequences) had significant antiapoptosis activity. These results
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first 4,658 LAT nucleotides except for nucleotides 76 to 447
(StyI-StyI). pLAT(1-2850)⌬Sty expresses the first 2,850 LAT
nucleotides except for nucleotides 76 to 447. Figure 2C shows
the LAT RNA expressed by the LAT3.3A virus and the identical LAT RNA expressed by the plasmid pLAT(1-1499). Figure 2D shows the LAT RNA expressed by the LAT2.9A virus
and the identical LAT RNA expressed by the plasmid pLAT(11499)⌬Sty (LAT nucleotides 1 to 76 plus 447 to 1499). Figure
2E shows plasmids corresponding to those in Fig. 2B, except
that they do not contain the StyI-StyI deletion.
Antiapoptosis activities of the LAT plasmids. Neuro-2A
cells were cotransfected with a plasmid expressing caspase 9
(to induce apoptosis), a plasmid expressing ␤-galactosidase (an
indicator of which cells were transfected), and the indicated
LAT plasmid (Fig. 3). Previous studies have demonstrated that
a LAT plasmid expressing the first 4.8 kb of LAT inhibits
caspase 9-induced apoptosis in transiently transfected Neuro2A cells (5). The cultures were stained for ␤-galactosidase 72 h
later, and the number of ␤-galactosidase-positive cells were

counted. The number of ␤-galactosidase-positive cells obtained when cells were transfected with the empty plasmid plus
the ␤-galactosidase plasmid was set to 100%. pLAT(1-1499),
which expresses the same LAT RNA as the virus LAT3.3A
with a high spontaneous reactivation phenotype, significantly
protected against caspase 9-induced apoptosis. This mapped a
LAT function capable of inhibiting caspase 9-induced apoptosis to within the same 1.5-kb region capable of producing a
wild-type spontaneous reactivation phenotype in rabbits. This
was consistent with our previous study in which we mapped a
LAT function capable of inhibiting sodium butyrate-, etoposide-, and Bax-induced apoptosis to the same location (6).
The large plasmids containing the same StyI-StyI deletion as
the dLAT371 virus with a wild-type spontaneous reactivation
phenotype [pLAT(1-4658)⌬Sty and pLAT(1-2850)⌬Sty] also
provided significant protection against caspase 9-induced apoptosis. There was no significant difference among these three
plasmids (Fig. 3) (P ⬎ 0.05). This showed another correlation
between LAT RNA’s antiapoptosis activity and its ability to
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FIG. 1. Schematic representation of wild-type and mutant viruses. (A) The prototypic HSV-1 genomic structure of wild-type (wt) McKrae is
shown at the top. The viral repeat regions are shown as open rectangles. TRL, terminal long repeat; IRL, internal (or inverted) long repeat; TRS,
terminal short repeat; IRS, internal (or inverted) short repeat. The unique long (UL) and the unique short (US) regions are each represented by
a solid line. Below the genomic structure, the LAT region (one in each long repeat) is shown in expanded form. The primary 8.3-kb LAT is shown
as a long arrow. The stable 2-kb LAT is shown as a solid rectangle. ⫹1 and the small arrow indicate LAT nucleotide ⫹1, the start of LAT
transcription. The relative locations of the ICP0 and ICP34.5 mRNAs are shown for reference. (B) dLAT2903 is a LAT null mutant. It contains
a deletion (xxxxx) in both copies of LAT from LAT nucleotide ⫺161 to ⫹1667 and is therefore missing the core LAT promoter, a putative
secondary LAT promoter just upstream of the 2-kb LAT, and the first 1,667 nucleotides of the primary LAT RNA (11). (C) dLAT371 contains
a deletion in both copies of LAT corresponding to a StyI-StyI restriction fragment from LAT nucleotides 76 to 447 (13). (D) LAT3.3A contains
a LAT restriction fragment inserted into the UL region of dLAT2903 between the UL37 and UL38 genes. The LAT insert contains the entire LAT
promoter and the first 1.5 kb of the primary LAT RNA. This virus transcribes only the first 1.5 kb of LAT (12). (E) LAT2.9A is identical to
LAT3.3A except that the LAT insert contains the same StyI-StyI deletion (LAT nucleotides 76 to 447) as dLAT371 (14).
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support the high spontaneous reactivation phenotype. In contrast, pLAT(1-1499)⌬Sty, which expresses the same LAT RNA
as the poorly reactivating LAT2.9A virus, did not provide significant protection against caspase 9-induced apoptosis (P ⬍
0.05 compared to the first three plasmids; P ⬎ 0.05 compared
to empty plasmid). This showed a correlation between an inability to block apoptosis and an inability to support the high
spontaneous reactivation phenotype for this LAT RNA.
LAT expression in all of the LAT-containing plasmids was
driven by the LAT promoter. Therefore, similar amounts of
LAT RNA should be transcribed following transfection. In the
caspase 9 and ␤-galactosidase plasmids used here, expression
was driven by the cytomegalovirus (CMV) promoter. We previously showed that LAT does not alter activity of this promoter (6). Thus, the amounts of caspase 9 and ␤-galactosidase
were not affected by the LAT plasmids.
The mutant viruses LAT3.3A and LAT2.9A express LAT
RNAs identical to those of pLAT(1-1499) and pLAT(1-1499)
⌬Sty, respectively, from an ectopic insert. We previously
showed that the steady-state levels of LAT(1-1499) RNA and
LAT(1-1499)⌬Sty RNA made by these viruses in tissue culture
are indistinguishable (14). We also found similar steady-state
levels of these transcripts in TG of rabbits latently infected
with LAT3.3A or LAT2.9A (14). Thus, the StyI-StyI deletion
(⌬LAT 76-447) does not appear to significantly alter the transcription or stability of these LAT RNAs. To confirm that
the same would be true for the corresponding plasmids used
above, we transfected Neuro-2A cells with either pLAT(1-

1499) or pLAT(1-1499)⌬Sty as was done for the transienttransfection assays. We then performed semiquantitative reverse transcriptase PCR (RT-PCR) with the same primers and
conditions that we previously used with the LAT3.3A and
LAT2.9A viruses discussed above. These primers amplify a
160-bp product specific for a region located downstream of the
StyI-StyI deletion and upstream of the start of the 2-kb LAT
(LAT nucleotides 471 to 631) (14). The amounts of the RTPCR product were similar with both plasmids (Fig. 4, lanes 1
and 2). No product was detected when RT was left out of the
reaction (Fig. 4, lanes 3 and 4). The RT-PCR product comigrated with the PCR products obtained from the pLAT(11499) plasmid and from wild-type virus (lanes 5 and 6). The
internal GAPDH (glyceraldehyde-3-phosphate dehydrogenase) RT-PCR control was similar in both extracts (lanes 7
and 8). Similar results were obtained in three separate experiments. Thus, the reduced LAT antiapoptosis activity seen
with pLAT(1-1499)⌬Sty was unlikely to be the result of reduced levels of LAT RNA compared to pLAT(1-1499).
Two additional plasmids, pLAT(1-2850) and pLAT(1-4658)
(Fig. 2E), were included in these experiments. The LAT regions in these plasmids correspond to the LAT regions in
pLAT(1-2850)⌬Sty and pLAT(1-4658)⌬Sty, except that the
StyI-StyI region (LAT nucleotides 76 to 447) is not deleted.
Both of these plasmids had similar antiapoptosis activity in this
assay, and this activity was significantly higher than that of the
corresponding ⌬Sty plasmids (Fig. 3).
Thus, the plasmids used here fell into three distinct groups
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FIG. 2. Schematic representation of LAT-containing plasmids. (A) Wild-type (wt) 8.3-kb primary LAT. The numbers show relative LAT
nucleotide locations. The pair of diagonal lines between 4658 and 8.3 kb depicts a break in the sequence, and thus this region is not drawn to scale.
The solid rectangle indicates the location of the stable 2-kb LAT. (B) dLAT371 indicates the RNA made by this mutant virus. This RNA has LAT
nucleotide 76 to 447 deleted (xx) but is otherwise full length. pLAT(1-4658)⌬Sty indicates the LAT RNA expressed by this plasmid. The same
StyI-StyI region is deleted, and the transcript terminates at LAT nucleotide 4658. pLAT(1-2850)⌬Sty indicates the LAT RNA expressed by this
plasmid. This contains the same StyI-StyI deletion, and the RNA terminates at LAT nucleotide 2850. (C) LAT3.3A indicates the LAT RNA (LAT
nucleotides 1 to 1499) made by this mutant virus. pLAT(1-1499) indicates the identical RNA made by this plasmid. (D) LAT2.9A indicates the
LAT RNA (LAT nucleotides 1 to 76 plus 447 to 1499) made by this mutant virus. pLAT(1-1499)⌬Sty indicates the identical LAT RNA expressed
by this plasmid. (E) pLAT(1-4658) and pLAT(1-2850) are the same as pLAT(1-4658)⌬Sty and pLAT(1-2850)⌬Sty in panel B, except that these
plasmids do not have the StyI-StyI region (LAT nucleotides 76 to 447) deleted.
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regarding their ability to block caspase 9-induced apoptosis (Fig. 3). (i) The empty plasmid and pLAT(1-1499)⌬Sty
had background activity (approximately 5% cell survival).
(ii) pLAT(1-1499), pLAT(1-2850)⌬Sty, and pLAT(1-4658)⌬Sty
had significant activity compared to the first group of plasmids
(approximately 25 to 30% cell survival). (iii) pLAT(1-2850)
and pLAT(1-4658) had significantly higher activity than the
second group of plasmids (approximately 45 to 50% cell survival). The plasmids within each group were significantly different from each of the plasmids in the other two groups (P ⬍
0.05).
Our previous studies demonstrated that LAT has antiapoptosis activity (6, 10). Despite some initial controversy, LAT’s
antiapoptosis activity has now been confirmed by two additional groups (1; Straus, personal communication). We hypothesize that LAT’s antiapoptosis activity may play a key role in
the ability of LAT to support the high spontaneous reactivation phenotype. This hypothesis was supported by our finding
that expression of just the first 1.5 kb of the primary 8.3-kb
LAT transcript is sufficient to both support the wild-type spontaneous reactivation phenotype (12) and to interfere with apoptosis in the same transient-transfection assay reported here
(6). Thus, LAT’s ability to support wild-type levels of sponta-

neous reactivation and a LAT antiapoptosis function both map
to the same 18% of LAT. This comapping is consistent with a
functional relationship between these two LAT functions and
supports our hypothesis that LAT’s antiapoptosis activity is
important in its ability to enhance the spontaneous reactivation
phenotype.
We previously found that in HSV-1 strain McKrae, deletion
of LAT nucleotides 76 to 447 (StyI-StyI) in the context of the
entire LAT gene (dLAT371) (13) does not reduce spontaneous
reactivation. In addition, we showed that insertion of the LAT
promoter and the first 1.5 kb of LAT (LAT3.3A) into an
ectopic location in the LAT null mutant dLAT2903 restored
the wild-type spontaneous reactivation phenotype (12). Since
LAT2.9A is identical to LAT3.3A except that it contains the
StyI-StyI deletion, it was expected that LAT2.9A would have a
wild-type spontaneous reactivation phenotype. However, reactivation of LAT2.9A was greatly reduced and indistinguishable
from that of the LAT null mutant dLAT2903 (14). At that time
we speculated that the LAT null mutant spontaneous reactivation phenotype of LAT2.9A might be due to the lack of a
portion of LAT from 1.5 to 8.3 kb. Thus, the StyI-StyI region
may not be required in the context of the otherwise complete
LAT gene but is needed when only the first 1.5 kb of LAT is
present. This would suggest that there is at least one additional
functional region that is located either partially or completely
downstream of the first 1.5-kb region. Furthermore, the functional region within the first 1.5 kb and the functional region(s)
spanning or downstream of nucleotide 1499 would each have
to be able to produce the wild-type spontaneous reactivation
phenotype, but the effects on spontaneous reactivation could
not be additive. This could occur if each functional region
resulted in the maximum spontaneous reactivation possible in
the rabbit model.
The spontaneous reactivation phenotypes of the above-described mutants presented us with the opportunity to further
test our hypothesis that LAT’s antiapoptosis activity is related
to its ability to enhance the spontaneous reactivation phenotype. Our hypothesis predicted that consistent with the reduced spontaneous reactivation phenotype of LAT2.9A, a

FIG. 4. Similar steady-state levels of pLAT(1-1499) and pLAT(11499)⌬Sty RNA following transfection of Neuro-2A cells. Neuro-2A
cells were transfected with the indicated LAT plasmid as described in
the legend to Fig. 3. At 48 h after transfection, total cell lysates were
prepared and semiquantitative RT-PCR was performed as we previously described (14). The primers used amplify a 160-bp product corresponding to LAT nucleotides 471 to 631 (14). Lane 1, pLAT(1499)
⌬Sty with RT; lane 2, pLAT(1499) with RT; lane 3, pLAT(1499)⌬Sty
with no RT; lane 4, pLAT(1499) with no RT; lane 5, marker [PCR of
purified pLAT(1499) plasmid]; lane 6, marker (PCR of purified HSV-1
virion DNA); lane 7, RT-PCR of GAPDH internal standard from an
aliquot of pLAT(1499)⌬Sty-transfected cell extract; lane 8, RT-PCR of
GAPDH internal standard from an aliquot of pLAT(1499)-transfected-cell extract.
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FIG. 3. Inhibition of caspase 9-induced apoptosis by plasmids expressing various portions of LAT. Neuro-2A cells were cotransfected
with 4 g of the indicated LAT plasmid (or empty plasmid), 2 g of a
plasmid expressing caspase 9 (5), and 1 g of a plasmid expressing
␤-galactosidase (pCMV–␤-Gal). All of the LAT fragments are expressed in these plasmids from the LAT promoter. Expression of caspase 9 and ␤-galactosidase is from the CMV promoter. As we previously described, at 72 h after transfection the cells were processed for
detection of ␤-galactosidase activity and the number of ␤-galactosidase-positive (blue) cells were counted (5). The number of ␤-galactosidase-positive cells present in control cultures (with 1 g of pCMV–
␤-Gal, 6 g of empty plasmid, and no caspase 9 plasmid) was set to
100%. The values shown are the means and standard deviations from
three different experiments. The results shown by the solid bars were
all similar to each other (P ⬎ 0.05). The results shown by the open bars
were also similar to each other (P ⬎ 0.05), as were the results shown
by the gray bars (P ⬎ 0.05). Each of the solid bars was significantly
different from each of the open bars and each of the gray bars (P ⬍
0.05).
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plasmid expressing LAT RNA identical to that expressed by
LAT2.9A would have little or no antiapoptosis activity. In
support of this prediction, pLAT(1-1499)⌬Sty did not inhibit
caspase 9-induced apoptosis. Our hypothesis also predicted
that consistent with the wild-type spontaneous reactivation
phenotype of dLAT371, a plasmid containing the same ⌬Sty
deletion (LAT nucleotides 76 to 447) but expressing a longer
LAT fragment more consistent with dLAT371 would efficiently
block apoptosis. In support of this prediction, both pLAT(12850)⌬Sty and pLAT(1-4658)⌬Sty inhibited caspase 9-induced
apoptosis as efficiently as the positive control plasmid pLAT
(1-1499). These results strongly supported our hypothesis
that LAT’s antiapoptosis activity plays an important role in
its spontaneous reactivation phenotype, since the ability to
enhance the spontaneous reactivation phenotype and the ability to block apoptosis correlated even with this rather complex
set of mutants and plasmids.
These results also strongly suggest that a LAT antiapoptosis
function that we previously mapped to completely within the
first 1.5 kb of LAT (6) completely or partially overlaps LAT
nucleotides 76 to 447 (the region deleted in LAT2.9A). Our
results also strongly suggest that there is a second LAT antiapoptosis region that maps somewhere between LAT nucleotides 447 and 2850, with at least part of this functional region
being located between LAT nucleotides 1500 and 2850. The
latter region includes approximately 58% of the 3⬘ end of the
LAT intron (also known as the stable 2-kb LAT), and the
location of the second LAT antiapoptosis region is therefore
consistent with the previously suggested hypothesis that the
LAT intron may play a role in LAT’s antiapoptotic activity (1).
The McKrae-based LAT mutants LAT3.3A (12) and dLAT371
(13), which express LAT RNA corresponding to the first and
second LAT antiapoptosis regions, respectively, both have
wild-type spontaneous reactivation phenotypes in the rabbit.
Thus, the results reported here also suggest that each of the
two LAT antiapoptosis regions alone may be sufficient for the
high spontaneous reactivation phenotype in rabbits. However,
it is likely that both regions are important in the latencyreactivation cycle in humans.
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